Ki-67, Cell Cycle Marker (MIB-1) Antibody from EXALPHA BIOLOGICALS, INC.
Search, find, compare suppliers for anti-Ki-67, Cell Cycle Marker (MIB-1) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Ki-67, Cell Cycle Marker (MIB-1) |
| Clone | MIB-1 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | unconjugated |
| Size | 5 ml |
| Concentration | n/a |
| Applications | Immunohistochemistry (frozen), Immunohistochemistry (paraffin), Immunohistochemistry (frozen), Immunohistochemistry (paraffin) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Ki-67, Cell Cycle Marker (MIB-1) |
| Immunogen | Human nuclear Ki-67 antigen |
| Other Names | n/a |
| Gene, Accession # | UniProt: P46013 |
| Catalog # | KI500 |
| Price | $505 |
| Order / More Info | Ki-67, Cell Cycle Marker (MIB-1) Antibody from EXALPHA BIOLOGICALS, INC. |
| Product Specific References | 1. Gerdes J., Schwab U., Lemke H., and Stein H. (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31; 13-20. 2. Gerdes J., Stein H., Pileri S., Rivano M.T., Gobbi M., Ralfkiaer E., Nielsen K.M., Pallesen G., Bartels H., Palestro G., and Delsol G. (1987) Prognostic relevance of the tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Letter to the editor: Lancet ii, 448-449. 3. Gerdes J., Becker M.H.G., Key G., and Cattoretti G. (1992) Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J. Pathol., 168; 85-86. 4. Kubbutat M.H.G., Cattoretti G., Gerdes J., Key G., (1994) Comparison of monoclonal antibodies PC10 and MIB-1 on microwave-processed paraffin sections. Cell Proliferation 27; 553-559. |
EXALPHA BIOLOGICALS, INC.
EXALPHA BIOLOGICALS, INC.
2 Shaker Road, Unit B101
Shirley MA 01464
P: 978-425-1370
info@exalpha.com
https://www.exalpha.com
Profile of EXALPHA BIOLOGICALS, INC.
Return to Antibodies